Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level
Maspin, a tumor suppressor (SERPINB5), inhibits cancer migration, invasion, and metastasis in vitro and in vivo. The tumor-suppressing effects of maspin depend in part on its ability to enhance cell adhesion to extracellular matrix. Although the molecular mechanism of maspin's action is still u...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84880309087&partnerID=40&md5=faaf729eb610f1e4b5ae8c6fb98e936c http://www.ncbi.nlm.nih.gov/pubmed/23924927 http://cmuir.cmu.ac.th/handle/6653943832/4156 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
id |
th-cmuir.6653943832-4156 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-41562014-08-30T02:35:44Z Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level Khanaree C. Chairatvit K. Roytrakul S. Wongnoppavich A. Maspin, a tumor suppressor (SERPINB5), inhibits cancer migration, invasion, and metastasis in vitro and in vivo. The tumor-suppressing effects of maspin depend in part on its ability to enhance cell adhesion to extracellular matrix. Although the molecular mechanism of maspin's action is still unclear, its functional domain is believed to be located at the reactive center loop (RCL). We have elucidated the role of maspin RCL on adhesion, migration, and invasion by transfecting the highly invasive human breast carcinoma MDA-MB-231 cell line with pcDNA3.1-His/FLAG containing wild-type maspin, ovalbumin, or maspin/ovalbumin RCL chimeric mutants in which maspin RCL is replaced by ovalbumin (MOM) and vice versa (OMO). MDA-MB-231 cells transfected with maspin- or OMO-containing recombinant expression plasmid manifested significant increase in adhesion to fibronectin and reduction in in vitro migration and invasion through Matrigel compared with mock transfection or cells transfected with ovalbumin or MOM. Proteomics analysis of maspin- or OMO-transfected MDA-MB-231 cells revealed reduction in contents of proteins known to promote cancer metastasis and those of ubiquitin-proteasome pathway, while those with tumor-suppressing properties were increased. Furthermore, MDA-MB-231 cells containing maspin or OMO transgene have significantly higher levels of ubiquitin and ubiquitinated conjugates, but reduced 20S proteasome chymotrypsin-like activity. These results clearly demonstrate that the tumor-suppressive properties of maspin reside in its RCL domain. Copyright © 2013 Cognizant Comm. Corp. 2014-08-30T02:35:44Z 2014-08-30T02:35:44Z 2013 Article 09650407 10.3727/096504013X13657689383175 23924927 ONREE http://www.scopus.com/inward/record.url?eid=2-s2.0-84880309087&partnerID=40&md5=faaf729eb610f1e4b5ae8c6fb98e936c http://www.ncbi.nlm.nih.gov/pubmed/23924927 http://cmuir.cmu.ac.th/handle/6653943832/4156 English |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
language |
English |
description |
Maspin, a tumor suppressor (SERPINB5), inhibits cancer migration, invasion, and metastasis in vitro and in vivo. The tumor-suppressing effects of maspin depend in part on its ability to enhance cell adhesion to extracellular matrix. Although the molecular mechanism of maspin's action is still unclear, its functional domain is believed to be located at the reactive center loop (RCL). We have elucidated the role of maspin RCL on adhesion, migration, and invasion by transfecting the highly invasive human breast carcinoma MDA-MB-231 cell line with pcDNA3.1-His/FLAG containing wild-type maspin, ovalbumin, or maspin/ovalbumin RCL chimeric mutants in which maspin RCL is replaced by ovalbumin (MOM) and vice versa (OMO). MDA-MB-231 cells transfected with maspin- or OMO-containing recombinant expression plasmid manifested significant increase in adhesion to fibronectin and reduction in in vitro migration and invasion through Matrigel compared with mock transfection or cells transfected with ovalbumin or MOM. Proteomics analysis of maspin- or OMO-transfected MDA-MB-231 cells revealed reduction in contents of proteins known to promote cancer metastasis and those of ubiquitin-proteasome pathway, while those with tumor-suppressing properties were increased. Furthermore, MDA-MB-231 cells containing maspin or OMO transgene have significantly higher levels of ubiquitin and ubiquitinated conjugates, but reduced 20S proteasome chymotrypsin-like activity. These results clearly demonstrate that the tumor-suppressive properties of maspin reside in its RCL domain. Copyright © 2013 Cognizant Comm. Corp. |
format |
Article |
author |
Khanaree C. Chairatvit K. Roytrakul S. Wongnoppavich A. |
spellingShingle |
Khanaree C. Chairatvit K. Roytrakul S. Wongnoppavich A. Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
author_facet |
Khanaree C. Chairatvit K. Roytrakul S. Wongnoppavich A. |
author_sort |
Khanaree C. |
title |
Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
title_short |
Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
title_full |
Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
title_fullStr |
Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
title_full_unstemmed |
Reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
title_sort |
reactive center loop moiety is essential for the maspin activity on cellular invasion and ubiquitin-proteasome level |
publishDate |
2014 |
url |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84880309087&partnerID=40&md5=faaf729eb610f1e4b5ae8c6fb98e936c http://www.ncbi.nlm.nih.gov/pubmed/23924927 http://cmuir.cmu.ac.th/handle/6653943832/4156 |
_version_ |
1681420184303173632 |